Capital City Bank Group, Inc. Appoints Jep Larkin Chief Financial Officer as J. Kimbrough Davis Announces Retirement

Written by Customer Service on August 25, 2022. Posted in Public Companies.

TALLAHASSEE, Fla., Aug. 25, 2022 (GLOBE NEWSWIRE) — Capital City Bank Group, Inc. (NASDAQ: CCBG) today announced that, effective January 1, 2023, Jep Larkin will be named Executive Vice President and Chief Financial Officer to succeed J. Kimbrough Davis, who has elected to retire after a distinguished 41 years with the company. Mr. Davis will continue his existing duties until December 31, 2022, while ensuring a smooth transition of responsibilities to Mr. Larkin. Mr. Larkin, 58, joined Capital City in 1986 and has worked closely with our CFO throughout his career. He is currently the Senior Vice President and Controller of CCBG and a member of the Senior Management Committee. After serving in various credit roles early in his career and leading CCBG’s Internal Audit Division from 1992 to 2002, he was appointed Controller of...

Inari Medical to Present at Upcoming Investor Conferences

Written by Customer Service on August 25, 2022. Posted in Public Companies.

IRVINE, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that its management team will present at the following investor conferences: 2022 Wells Fargo Healthcare ConferenceFireside chat on Friday, September 9, 2022, at 8:35 a.m. Eastern Time in Boston, MA. Morgan Stanley 20th Annual Global Healthcare ConferenceFireside chat on Monday, September 12, 2022, at 8:10 a.m. Eastern Time in New York, NY. A live audio webcast and replay of the Wells Fargo and Morgan Stanley conference may be accessed on the “Investor Relations” section of the company’s website at: https://www.inarimedical.com/ About Inari Medical, Inc.Inari Medical, Inc. is a medical device...

Freddie Mac Issues Monthly Volume Summary for July 2022

Written by Customer Service on August 25, 2022. Posted in Public Companies.

MCLEAN, Va., Aug. 25, 2022 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today posted to its website its Monthly Volume Summary for July 2022, which provides information on Freddie Mac’s mortgage-related portfolios, securities issuance, risk management, delinquencies, debt activities, and other investments. Freddie Mac makes home possible for millions of families and individuals by providing mortgage capital to lenders. Since our creation by Congress in 1970, we’ve made housing more accessible and affordable for homebuyers and renters in communities nationwide. We are building a better housing finance system for homebuyers, renters, lenders, and taxpayers. Learn more at FreddieMac.com, Twitter @FreddieMac, and Freddie Mac’s blog FreddieMac.com/blog. MEDIA CONTACT: Fred Solomon703-903-3861Frederick_Solomon@freddiemac.com INVESTOR...

Urbanimmersive Announces Its 2022 Third Quarter Financial Results

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

SAINT-HUBERT, Quebec, Aug. 25, 2022 (GLOBE NEWSWIRE) — Urbanimmersive Inc. (“Urbanimmersive,” the “Company” or “UI”) (TSV-V UI) (OTCQB: UBMRF) today announced select financial results and presents business highlights for its third quarter ended June 30, 2022. The financial statements and related management’s discussion and analysis (“MD&A”) can be viewed on SEDAR at https://www.sedar.com/. HIGHLIGHTS For its third quarter ended on June 30, 2022 (Q3-22), the Company’s revenues totaled $2,850k compared to $1,102k for Q3-21, an increase of +$1,748k or 159%; For Q3-22, the Company sold 6,270 immersive 3D tours compared to 1,551 tours in Q3-21, an increase of 4,719 tours (304%); For Q3-22, EBITDA totalled $296k compared to $103k for Q3-21, an increase of $193k; For Q3-22, operating activities generated cash flows of +$365k...

MDxHealth Reports Half Year 2022 Results

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

NEWS RELEASE – REGULATED INFORMATION25 AUGUST 2022, 4:00PM EDT, 22:00 CET MDxHealth Reports Half Year 2022 Results IRVINE, CA, and HERSTAL, BELGIUM – August 25, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH) (“mdxhealth” or the “Company“), a commercial-stage precision diagnostics company, today announced its financial results for the half year ended June 30, 2022. Michael K. McGarrity, CEO of mdxhealth, commented: “We are excited to report strong operating results for the first half of 2022, coupled with our recently announced acquisition of the Oncotype DX GPS business from Exact Sciences. Our first half 2022 performance reflects the continued execution of our growth strategy and provides a strong foundation for driving sustained growth for mdxhealth.” Key Financial and Corporate Highlights for the half year...

Crown Castle to Present at the Bank of America 2022 Media, Communications & Entertainment Conference

Written by Customer Service on August 25, 2022. Posted in Public Companies.

HOUSTON, Aug. 25, 2022 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) announced today that Dan Schlanger, Crown Castle’s Executive Vice President and Chief Financial Officer, is scheduled to present on Thursday, September 8, 2022 at 12:40 p.m. Eastern Time at the Bank of America 2022 Media, Communications & Entertainment Conference. The presentation will be broadcast live over the Internet and is expected to last approximately 40 minutes. The live audio webcast link and presentation for the conference will be available on Crown Castle’s website at www.crowncastle.com, where it will also be archived for replay. ABOUT CROWN CASTLE Crown Castle owns, operates and leases more than 40,000 cell towers and approximately 85,000 route miles of fiber supporting small cells and fiber solutions across every...

Kane Biotech Announces Second Quarter 2022 Financial Results

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

Significant Milestones Achieved WINNIPEG, Manitoba, Aug. 25, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its second quarter 2022 financial results. Second Quarter Financial Highlights: Total revenue for the three months ended June 30, 2022 was $839,579, an increase of 201% compared to $278,741 in the three months ended June 30, 2021. License revenue in the three months ended June 30, 2022 was $500,225, an increase of 1,295% compared to $35,872 in the three months ended June 30, 2021. This substantial increase is due to the Company’s subsidiary, STEM Animal Health, achieving a key milestone in April, 2022, namely the Veterinary Oral Health Council (“VOHC”) Seal of Acceptance in the Helps Control Tartar category, which triggered approximately $1.3 million...

Reviv3 Procare Reports Record 2022 Financial Results and Provides Business Updates

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

Record Fiscal Year 2022 revenue of $2.3 Million reflects 43% year-over-year growth. Company expects revenue for Q1 ending August 31, 2022 exceeding $3.4 Million, a substantial increase compared to the same prior year period, primarily as a result of the previously announced asset acquisition of AXIL & Associated Brands. LOS ANGELES, Aug. 25, 2022 (GLOBE NEWSWIRE) — Reviv3 Procare Company (OTCQB: RVIV), an emerging global e-commerce brand in hair care products industry and hearing protection and enhancement products, today announced its financial and operational results for fiscal year ended May 31, 2022. Fiscal Year End 2022 Financial Summary Revenues increased 43% to $2,336,257 compared to $1,633,609 in the previous year, primarily driven by our marketing initiatives in the direct-to-consumer sales channels. Gross profit...

Alpha Tau Medical Announces Second Quarter 2022 Financial Results and Provides Corporate Update

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

–Received FDA Conditional Investigational Device Exemption (IDE), whose conditions have since been satisfied, to initiate a pivotal trial of Alpha DaRT™ in recurrent cutaneous squamous cell carcinoma. The Company expects to treat its first patient in this study later in 2022– –Treated first patient in a feasibility study evaluating the Alpha DaRT as a neoadjuvant therapy in patients with prostate cancer- JERUSALEM, Aug. 25, 2022 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS and DRTSW), (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, reported second quarter 2022 financial results and provided a corporate update. “We have made significant progress by gaining conditional FDA approval, whose conditions have since been satisfied,...

Lantronix Reports Record Results for Fourth Quarter and Fiscal 2022

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

Fourth Quarter Net Revenue of $35.9 Million, up 74 Percent Year-Over-Year Fourth Quarter GAAP EPS of $0.07 vs. ($0.04) in the Prior Year Fourth Quarter Non-GAAP EPS of $0.08 vs. $0.06 in the Prior Year Initiates Full Year Fiscal 2023 Revenue Guidance to a range of $149 Million to $162 Million IRVINE, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of secure turnkey solutions for Intelligent IT and Internet of Things (IoT), today reported record results for its fourth quarter of fiscal 2022. Net revenue totaled $35.9 million, up 74 percent year-over-year and up 11 percent sequentially. GAAP EPS of $0.07, compared to ($0.04) in the prior year and ($0.09) in the prior quarter. Non-GAAP EPS of $0.08, compared to $0.06 in the prior year and $0.08 in the prior quarter. Business Outlook While...

Day: August 25, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice